Managing Medication Administration

Managing Medication Administration

Why This Skill Exists

Medication errors are the most common type of healthcare error, with the Institute for Safe Medication Practices (ISMP) identifying administration as the highest-risk phase of the medication use process. The Joint Commission NPSG.03.04.01 requires labeling of all medications and solutions. NPSG.03.05.01 mandates anticoagulant safety protocols. NPSG.03.06.01 requires medication reconciliation at transitions. CMS Conditions of Participation (§482.23) require that drugs and biologicals are administered per physician orders and accepted standards of practice. The ANA Scope and Standards designate medication administration as a core nursing competency requiring clinical judgment — not just task completion. This skill ensures safe, accurate, well-documented medication administration aligned with current evidence-based practice.

Checkpoint A — Intake Verification

Required Before Medication Administration

• Valid medication order with all required elements: patient name, medication name, dose, route, frequency, indication (where required by facility policy)
• Allergy status verified and documented — including type of reaction for each allergy
• Current medication reconciliation complete
• Patient weight in kilograms for weight-based dosing
• Relevant laboratory values checked (e.g., INR for warfarin, potassium for KCl, renal function for renally-cleared drugs, vancomycin trough)
• Patient assessment appropriate to the medication (e.g., heart rate before beta-blockers or digoxin, BP before antihypertensives, blood glucose before insulin, respiratory rate before opioids)
• High-alert medication independent double-check completed if applicable

High-Alert Medication Identification

Per ISMP High-Alert Medications List, the following require enhanced safeguards:

• Anticoagulants (heparin, warfarin, DOACs)
• Insulin (all formulations)
• Opioids (all formulations and routes)
• Neuromuscular blocking agents
• Concentrated electrolytes (potassium chloride, hypertonic saline, magnesium sulfate)
• Chemotherapy/antineoplastic agents
• Epidural and intrathecal medications

Step 1 — Verify the Ten Rights of Medication Administration

Perform rights verification at three checkpoints: when retrieving from storage, when preparing, and at the bedside before administration.

1. Right Patient — verify using two identifiers (name + DOB or name + MRN); never use room number as an identifier
2. Right Medication — compare label to MAR; for sound-alike/look-alike medications (ISMP list), use tall-man lettering awareness
3. Right Dose — confirm dose is appropriate for age, weight, renal/hepatic function; perform dosage calculation if needed
4. Right Route — verify the ordered route; confirm patient can receive via that route (e.g., can swallow PO, has IV access for IV)
5. Right Time — administer within 30 minutes before or after scheduled time (per CMS interpretive guidance); time-critical medications have narrower windows
6. Right Documentation — document immediately after administration, never before
7. Right Reason — understand the clinical indication; question orders that lack clinical justification
8. Right Assessment — perform pre-administration assessment specific to the medication
9. Right Education — inform the patient about the medication name, purpose, expected effects, and what to report
10. Right Evaluation — plan and perform post-administration assessment for therapeutic and adverse effects

Step 2 — Perform Barcode Medication Administration (BCMA)

1. Scan patient wristband to verify identity
2. Scan each medication to verify against the electronic MAR
3. Address any BCMA override alerts — document clinical rationale for any alert overridden
4. Never pre-scan or batch-scan medications before reaching the patient's bedside
5. Report BCMA system downtime per institutional downtime medication administration procedure
6. Document BCMA scanning compliance for unit-level quality metrics

Step 3 — Execute Route-Specific Administration

Oral Medications

• Verify swallowing ability; assess for dysphagia risk
• Elevate HOB to at least 30 degrees before administering
• Do not crush extended-release, enteric-coated, or sublingual formulations — consult pharmacy for alternatives
• Administer with appropriate fluid unless fluid-restricted

Intravenous Medications

• Verify IV site patency and assess for infiltration/phlebitis (INS phlebitis scale)
• Confirm compatibility with running infusions — use separate lumens or flush between incompatible drugs
• Program smart pump with drug library entry; verify rate, concentration, and total volume
• For IV push medications: confirm push rate per pharmacy reference (e.g., IV push morphine over 4–5 minutes)

Subcutaneous / Intramuscular Injections

• Select appropriate site and needle length for patient body habitus
• Rotate injection sites for repeated doses (insulin, heparin)
• For insulin: verify type, dose, and units with independent double-check; use insulin-specific syringes only
• For IM: aspirate per current evidence and institutional policy (note: aspiration no longer recommended for most IM sites except dorsogluteal per CDC immunization guidelines)

Topical, Rectal, Ophthalmic, Otic, Inhaled

• Follow route-specific administration technique
• Document exact site of application for topical medications
• For inhaled medications: assess technique and provide spacer if appropriate

Step 4 — Manage High-Alert Medications

1. Independent double-check by a second RN for: insulin, heparin infusions, PCA settings, chemotherapy, blood products, pediatric weight-based doses, and other facility-designated high-alert medications
2. Double-check must verify: right patient, right medication, right dose, right route, right rate (for infusions), pump settings, and dosage calculation
3. Document the double-check with both nurses' signatures
4. Smart pump hard stops must never be overridden for high-alert medications without pharmacist consultation
5. Titration protocols: follow evidence-based titration parameters (e.g., insulin drip per institutional glycemic management protocol; heparin per weight-based nomogram)

Step 5 — Monitor Post-Administration

1. Assess for therapeutic effect at the expected onset time:
   • IV morphine: 5–10 minutes
   • PO acetaminophen: 30–60 minutes
   • Insulin lispro: 15–30 minutes
   • IV furosemide: 5 minutes (diuresis within 30 min)
2. Monitor for adverse effects and allergic reactions
3. Document patient response in the clinical notes
4. Report adverse drug reactions to the provider and pharmacy
5. Submit MedWatch (FDA) reports for serious adverse events per institutional policy
6. Reassess pain within 1 hour PO / 30 minutes IV per institutional pain reassessment protocol

Step 6 — Document Medication Administration

1. Record in the electronic MAR: medication name, dose, route, site (for injections), time administered, administering nurse
2. Document pre-administration assessment findings (BP, HR, glucose, pain score, etc.)
3. Document post-administration evaluation including patient response
4. Record patient refusal with reason stated, education provided about consequences, and provider notification
5. Document held medications with clinical rationale (e.g., "Metoprolol 25mg PO held — HR 52, physician notified at 0830, order received to hold if HR < 60")
6. Record PRN medication indication at time of administration and effectiveness at reassessment

Checkpoint B — Shift Medication Review

End-of-Shift Verification

• All scheduled medications administered or accounted for (given, held, refused, patient off unit)
• All PRN medications have documented indication and effectiveness reassessment
• All held medications have clinical rationale and provider notification documented
• No overdue medications pending
• Controlled substance count reconciled per institutional policy
• High-alert medication double-checks all documented with two RN signatures

Transition-of-Care Medication Safety

• Oncoming nurse briefed on medication-relevant findings (next dose times, pending labs, titration parameters)
• Any medication changes communicated via structured handoff
• Medication reconciliation current for any transfers (unit-to-unit, facility-to-facility)

Quality Audit

• Ten rights verified at all three checkpoints (retrieval, preparation, bedside)
• BCMA scanning compliance ≥ 95% per NDNQI benchmark
• High-alert medication independent double-checks completed and documented
• Smart pump drug library compliance ≥ 95%
• Pre-administration assessments documented for assessment-dependent medications
• Medication errors reported through institutional event reporting system (no punitive culture)
• Controlled substance documentation reconciles with dispensing records
• Time-critical medications administered within narrow window per CMS guidance
• Compliant with Joint Commission NPSG.03.04.01 (labeling), NPSG.03.05.01 (anticoagulant safety), NPSG.03.06.01 (reconciliation)
• Meets ANA Scope and Standards for safe medication administration

Guidelines

• Joint Commission NPSGs: NPSG.03.04.01 (labeling), NPSG.03.05.01 (anticoagulant safety), NPSG.03.06.01 (medication reconciliation at transitions of care)
• CMS CoP §482.23: Drugs and biologicals must be prepared and administered per accepted standards; orders must be documented and signed
• ISMP Guidelines: Follow ISMP High-Alert Medications List, Tall-Man Lettering list, and error-prevention recommendations
• ANA Position Statement: Safe medication administration requires clinical judgment, assessment, and monitoring — not mere task performance
• Controlled substances: DEA Schedule II–V medications require additional documentation, reconciliation, and chain-of-custody per federal and state law
• Scope of practice: RN independently administers medications per valid order; LPN/LVN administers per state Nurse Practice Act (IV push often restricted to RN); student nurses administer under direct RN supervision
• Error reporting: Report all medication errors and near-misses per institutional policy; foster a just culture approach that focuses on system improvement rather than individual blame
• Look-alike/sound-alike: Use tall-man lettering (e.g., DOBUTamine vs. DOPamine, hydrALAZINE vs. hydrOXYzine) and physical separation in storage